Trial intelligence / Profile preview

Fuke Zaizao Pill (Capsule) plus progesterone for menstrual regulation in polycystic ovary syndrome

ChiCTR2200066957Phase 4Recruiting

Sponsor
Women's Hospital, School of Medicine, Zhejiang University
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Fuke Zaizao Wan and progesterone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Menstrual condition and Quality of life. Started Jan 2023; status: recruiting.

02

Drugs

Fuke Zaizao Wanprogesterone
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR2200066957.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066957.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call